The Corona Remedies IPO began on 08-December-2025. It will close on 10-December-2025. The Total IPO Size is 655.37 Crores. The company set its IPO price at 1008-1062 Rs Per Share.
There are three basic categories in Corona Remedies IPO Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.
Corona Remedies is a India-focused branded pharmaceutical formulation company and engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas.
They have diversified product portfolio comprises 71 brands catering to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (“VMN”), gastrointestinal and respiratory).
The manufacturing facility, located at Survey No. 503, Mouje – Bhayla, Taluka Bavla, Ahmedabad, Gujarat.
Corona Remedies IPO Promoters
Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta and Ankur Kirtikumar Mehta. are the promoters of the company.
Corona Remedies IPO Date, Details & Price Band
The Corona Remedies IPO Price Band, IPO Dates, Market lot and other details mentioned in the table below.
| IPO Opening Dates | 08-December-2025 |
| IPO Closing Dates | 10-December-2025 |
| Price | 1008-1062 Rs |
| Fresh Issue | NIL |
| Offer for sale | 655.37 Cr |
| Total IPO size | 655.37 Cr |
| Face Value | 10 INR Per Share |
| Issue Type | Book Built Issue |
| QIB Allocation | 50% |
| HNI Allocation | 15% |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Corona Remedies IPO Market Lot
The Corona Remedies IPO minimum market lot is 14 shares with a 14,868 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 14 | 14,868 ₹ |
| Retail Maximum | 13 | 182 | 1,93,284 ₹ |
| S-HNI Minimum | 14 | 196 | 2,08,152 ₹ |
| S-HNI Maximum | 67 | 938 | 9,96,156 ₹ |
| B-HNI Minimum | 68 | 952 | 10,11,024 ₹ |
Restated Consolidated Financial Information (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 30-Jun-25 | 1,012.38 | 348.56 | 46.20 |
| 31-Mar-25 | 929.86 | 1,202.35 | 149.43 |
| 31-Mar-24 | 830.58 | 1,020.93 | 90.50 |
| 31-Mar-23 | 595.02 | 891.10 | 84.93 |
Corona Remedies IPO (Object of the Issue)
1. BRLMs fees and commissions (including underwriting commission, brokerage and selling commission)
2. Fees payable to the Registrar to the Offer;
3. Selling commission/processing fee for SCSBs and Bankers to the Offer, fee payable to the Sponsor Bank(s) for Bids made by RIIs using UPI, brokerage and selling commission and bidding charges for the Members of the Syndicate, Registered Brokers, RTAs and CDPs;
4. Advertising and marketing expenses
5. Others: Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees
6. Other regulatory expenses
7. Fees payable to legal counsels, statutory auditors, independent chartered accountants, practising company secretary, intellectual property consultants, industry service provider and others
8. Printing and distribution of issue stationery
9. Miscellaneous
Corona Remedies IPO GMP & Grey Market Premium
The Corona Remedies IPO GMP (Grey Market Premium) has started today. Check the Latest Corona Remedies IPO GMP, Kostak Rates, and Subject to Sauda Price here.
Corona Remedies IPO Prospectus
The Corona Remedies IPO Prospectus is Available on the NSE/BSE and SEBI websites, as well as on our Portal. Please click here to download the Corona Remedies IPO Prospectus.
| DRHP | Download |
| RHP | Download |
| Anchor Investor List | Download |
Corona Remedies IPO Allotment Date & Details
| Allotment Date | 11-Dec-2025 |
| Initiation of refunds | 12-Dec-2025 |
| Transfer of shares to Demat accounts | 12-Dec-2025 |
| Listing Date | 15-Dec-2025 |
| Check Allotment Status | Click here |
Registrar of Corona Remedies
Bigshare Services Private Limited
S6-2, 6th Floor, Pinnacle Business Park
Mahakali Caves Road, Next to Ahura Centre
Andheri (East), Mumbai 400 093
Maharashtra, India
Tel: +91 22626 38200
E-mail: [email protected]
Investor Grievance E-mail:
[email protected]
Website: www.bigshareonline.com
Contact Person: Babu Rapheal C.
SEBI Registration No.: INR000001385
Corona Remedies Contact Details
WAKEFIT INNOVATIONS LIMITED
Umiya Emporium,
97-99, 2nd and 4th Floor, Adugodi,
Tavarekere, Opp. Forum Mall,
Hosur Road, Bengaluru 560 029,
Karnataka, India
Tel: 080 6733 5544;
Website: www.wakefit.co;
Contact person: Surbhi Sharma,
Company Secretary and Compliance Officer;
E-mail: [email protected];
Corporate Identity Number: U52590KA2016PLC086582
Corona Remedies IPO Lead Managers
Kotak Mahindra Capital Company Limited
IIFL Capital Services Limited (formerly known as IIFL Securities Limited)
JM Financial Limited
